Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
Published: September 23, 2013
- Cardiopulmonary diseases - are 3rd leading cause of death in survivors of childhood cancer
- 24% of childhood cancer survivors - are greater than 30 years from initial diagnosis
- Stroke among survivors - almost 10 times higher compared to siblings
Supporting Materials
- Commentary: A Lifelong Perspective on the Cardiovascular Toxicity of Cancer Therapy in Children by Elske Sieswerda and Robert G. Weintraub
- Top Things to Know: Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
Recommended Reading
- Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth
- Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research
- Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge
- Indications for Heart Transplantation in Pediatric Heart Disease
- Cardiovascular Risk Reduction in High-Risk Pediatric Patients
- Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth